跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
autologous MSCs
首页
药物
autologous MSCs
autologous MSCs
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
US 9095562 B2
申请人: CENTENO CHRISTOPHER J
优先权: 2007
CN
US
4 件公开
APPLICATION OF SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS (MSCS) FOR CARTILAGE OR MENISCUS REGENERATION
US 2010178274 A1
申请人: SEKIYA ICHIRO
优先权: 2006
US
COMPOSITIONS, CELLS, KITS AND METHODS FOR AUTOLOGOUS STEM CELL THERAPY
US 2013302293 A1
申请人: WEBSTER KEITH A
优先权: 2011
US
STEM CELLS AS AN INDIVIDUALIZED MATERNAL THERAPY FOR PREVENTION OF PREMATURITY
US 2015110751 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2013
US
Application of autologous adipose-derived mesenchymal stem cells in preparation of medicines for treating joint diseases
CN 103550256 A
申请人: NANJING YOUER BIOTECHNOLOGY DEV CO LTD
优先权: 2013
CN
Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto
US 10828331 B2
申请人: UNIV EMORY
优先权: 2017
US
Pluripotent stem cell derivative for expressing PD-1/PD-L1 blocker and application
CN 114276996 A
申请人: FUTURE CHILDREN REGENERATIVE MEDICINE RES INSTITUTE GUANGZHOU CO LTD
优先权: 2020
CN
Pluripotent stem cell derivative for expressing IL-12 and application of pluripotent stem cell derivative
CN 114426953 A
申请人: FUTURE CHILDREN REGENERATIVE MEDICINE RES INSTITUTE GUANGZHOU CO LTD
优先权: 2020
CN
Pluripotent stem cell derivative for expressing IL-2 and application of pluripotent stem cell derivative
CN 114507643 A
申请人: FUTURE CHILDREN REGENERATIVE MEDICINE RES INSTITUTE GUANGZHOU CO LTD
优先权: 2020
CN
Pluripotent stem cell expressing CD47 antibody as well as derivative and application of pluripotent stem cell
CN 114457021 A
申请人: FUTURE CHILDREN REGENERATIVE MEDICINE RES INSTITUTE GUANGZHOU CO LTD
优先权: 2020
CN
第 1 / 4 页
上一页
下一页
药物
反馈